{"nct_id":"NCT00612534","title":"A Multicenter, Randomized, Placebo-Controlled Phase 2 Study to Evaluate the Clinical Efficacy, Safety, and Tolerability of ARX-F01 Sublingual Sufentanil in Patients Undergoing Elective Unilateral Total Knee Replacement","status":"COMPLETED","status_verified_date":"2014-01","start_date":"2008-03","start_date_type":null,"primary_completion_date":"2008-10","primary_completion_date_type":"ACTUAL","completion_date":"2008-10","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["TLPH"]}